The global Phototherapy Market is witnessing steady expansion, driven by the increasing prevalence of skin disorders, rising cases of neonatal jaundice, and growing adoption of advanced light-based treatment technologies. According to the latest industry analysis, the global phototherapy market size was valued at USD 669.32 million in 2025 and is projected to grow from USD 701.44 million in 2026 to USD 1,020.66 million by 2034, registering a CAGR of 4.8% during the forecast period (2026–2034). The growing demand for non-invasive treatment options, expanding healthcare infrastructure, and increasing awareness regarding phototherapy applications are contributing significantly to market growth. In addition, technological advancements in LED-based phototherapy systems and rising investments in neonatal care and dermatological treatment solutions are creating favorable opportunities for industry participants worldwide.

Market Dynamics

The growth of the phototherapy market is primarily fueled by the increasing prevalence of severe skin diseases such as psoriasis, vitiligo, eczema, acne, and cutaneous T-cell lymphoma. Skin conditions remain among the leading causes of non-fatal disease burden globally, increasing the demand for effective and safe treatment options. Phototherapy has emerged as a preferred therapeutic approach due to its proven efficacy and relatively low side-effect profile. Furthermore, the growing number of premature births and neonatal jaundice cases worldwide is accelerating demand for neonatal phototherapy equipment. Healthcare providers continue to adopt advanced phototherapy systems that offer improved precision, safety features, energy efficiency, and enhanced patient outcomes.

Technological innovation remains a key trend shaping the market landscape. The adoption of LED-based phototherapy equipment, fiberoptic systems, and portable home-use phototherapy devices is expanding rapidly. Growing interest in home phototherapy solutions for chronic skin disease management is creating new growth opportunities, as these systems provide convenience, cost-effectiveness, and improved patient compliance. Government initiatives supporting maternal and child healthcare, increasing investments in healthcare infrastructure across emerging economies, and rising awareness of advanced dermatological treatments further support market expansion. However, varying levels of technology adoption, healthcare expenditure, reimbursement frameworks, and awareness across different countries may present challenges to widespread market penetration.

Market Segmentation

By Product

• Conventional Phototherapy Equipment
• Conventional Phototherapy Equipment with Fluorescent Lamp

By Application

• Skin Disease Treatment
• Neonatal Jaundice Management
• Sterilization

By End User

• Hospital and Clinic
• Dermatology Center

By Region

• North America
• Europe
• Asia-Pacific (APAC)
• Middle East and Africa
• Latin America (LATAM)

Regional Insights

• North America dominates the phototherapy market and is expected to grow at a CAGR of 4.40% during the forecast period, supported by high adoption of advanced skincare technologies and increasing prevalence of skin disorders.
• Asia-Pacific represents the fastest-growing regional market, driven by improving healthcare infrastructure, rising preterm birth rates, increasing neonatal jaundice cases, and growing awareness of phototherapy treatments across developing economies.
• Europe continues to benefit from strong healthcare systems and increasing utilization of advanced phototherapy devices for dermatological applications.
• Latin America and the Middle East & Africa are witnessing gradual market expansion due to improving healthcare access and rising investments in medical technologies.

Latest Key Players

1. Signify Holding
2. GE Healthcare
3. Natus Medical Incorporated
4. Herbert Waldmann GmbH and Co. KG
5. Phoenix Medical Systems (P) Ltd
6. Atom Medical Corporation

Recent industry developments continue to strengthen the competitive landscape. In February 2022, STRATA Skin Sciences announced the commercial launch of XTRAC Momentum 1.0, its next-generation excimer laser technology designed for targeted UVB light therapy in psoriasis, vitiligo, and atopic dermatitis treatment. Additionally, in March 2023, AbbVie reported positive long-term efficacy and safety results for SKYRIZI® (risankizumab) in plaque psoriasis patients with prior suboptimal responses to IL-17 inhibitor therapy, highlighting continued innovation within dermatological treatment markets.

Click Here to Access the Comprehensive Report: https://straitsresearch.com/report/phototherapy-market

About Straits Research

Straits Research is a leading market intelligence and consulting firm delivering comprehensive research, analytics, and advisory services to organizations worldwide. The company specializes in providing actionable insights, customized research solutions, industry forecasting, competitive intelligence, market opportunity assessment, and strategic recommendations across diverse industry verticals. With a strong focus on accuracy, innovation, and data-driven decision-making, Straits Research helps businesses identify emerging trends, evaluate market dynamics, and formulate effective growth strategies. Its extensive research methodology combines primary and secondary analysis to provide reliable market intelligence that supports informed business decisions and sustainable long-term growth.